Adiponectin

Discovery and Characterization

Adiponectin was independently identified in 1995-1996 by four research groups using different experimental approaches, variously termed Acrp30, adipoQ, apM1, and GBP28. The gene encodes a 244-amino acid protein with a signal sequence, a variable region, a collagenous domain, and a C-terminal globular domain. Adiponectin is the most abundantly secreted adipokine, with plasma concentrations in the microgram-per-milliliter range, approximately 1000-fold higher than most other adipokines. Paradoxically, adiponectin levels are reduced in obesity and inversely correlate with insulin resistance, type 2 diabetes, and cardiovascular risk.

Oligomeric Assembly

Adiponectin circulates in multiple oligomeric forms: trimers, hexamers, and high-molecular-weight (HMW) multimers. The collagen domain mediates trimerization, while the globular C-terminal domain retains biological activity in isolation. The HMW form, stabilized by disulfide bond formation at Cys36 within the collagen domain, exhibits the greatest insulin-sensitizing activity. The ratio of HMW to total adiponectin has been proposed as a more clinically relevant biomarker than total adiponectin concentration.

Receptors and Signaling

Adiponectin signals through two seven-transmembrane domain receptors: AdipoR1, with high affinity for globular adiponectin, and AdipoR2, preferring full-length adiponectin. Both receptors are widely expressed, with AdipoR1 predominant in skeletal muscle and AdipoR2 in liver. Unlike classical G protein-coupled receptors, AdipoR1 and AdipoR2 contain seven transmembrane domains with the N-terminus intracellular and the C-terminus extracellular. Downstream signaling includes AMPK activation, PPARalpha agonism, and ceramidase activity, collectively promoting fatty acid oxidation and glucose uptake.

Insulin-Sensitizing Effects

Adiponectin enhances hepatic insulin sensitivity by suppressing gluconeogenic enzyme expression and promoting fatty acid oxidation through AMPK activation. In skeletal muscle, adiponectin stimulates glucose uptake via GLUT4 translocation and increases fatty acid oxidation by inhibiting ACC and activating CPT1. Adiponectin knockout mice develop insulin resistance, hepatic steatosis, and impaired glucose tolerance when fed a high-fat diet. The protective effects extend to direct suppression of hepatic lipogenesis through SREBP-1c inhibition.

Anti-Inflammatory and Cardiovascular Protection

Adiponectin suppresses TNF-alpha and IL-6 production while stimulating anti-inflammatory cytokines IL-10 and IL-1RA. The peptide inhibits endothelial NF-kappaB signaling and reduces monocyte adhesion to vascular endothelium. In atherosclerotic lesion models, adiponectin accumulates in injured arterial walls and promotes endothelial repair. Epidemiological studies consistently demonstrate inverse associations between adiponectin levels and cardiovascular disease incidence.

References

1. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry. 1995;270:26746-26749.
2. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Reviews. 2005;26:439-451.
3. Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55:2319-2326.